# QUILT-3.033: Haplo NK With SQ ALT-803 for Adults With Relapsed or Refractory AML

> **NCT03050216** · PHASE2 · COMPLETED · sponsor: **Masonic Cancer Center, University of Minnesota** · enrollment: 8 (actual)

## Conditions studied

- Acute Myeloid Leukemia

## Interventions

- **BIOLOGICAL:** ALT-803

## Key facts

- **NCT ID:** NCT03050216
- **Lead sponsor:** Masonic Cancer Center, University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-16
- **Primary completion:** 2019-12-15
- **Final completion:** 2019-12-15
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2023-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03050216

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03050216, "QUILT-3.033: Haplo NK With SQ ALT-803 for Adults With Relapsed or Refractory AML". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03050216. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*